Euro India Fresh (EIFFL)

FairStock Score: 21/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding is high at 73.5%, aligning interests with minority shareholders.
• Latest quarter remains profitable with ₹1 crore net profit on ₹28 crore sales.
• ROCE is positive at 9.9%, indicating some operating capital efficiency.
• Debt-to-equity of 0.85 is moderate and not yet alarming.

Concerns

• Sales growth of -40.6% and profit growth of -48.57% show severe business contraction.
• P/E of 198.66 and P/B of 8.52 are excessive for a company with declining earnings and book value of ₹29.12.
• Piotroski F-score of 3/9 signals weak fundamental health and rising distress risk.
• Dividend yield is 0.00%, offering no compensation for shareholders while waiting.

AI Analysis

When I first glance at Euro India Fresh, the numbers shout caution. Sales are down 40.6% and profits down 48.57%. A healthy business does not shrink by two-fifths in a year. The latest quarter confirms the erosion: just ₹28 crore in sales and ₹1 crore net profit. At a market cap of ₹578 crore, I am paying 198 times trailing earnings for a company that is visibly contracting. Benjamin Graham taught me that price is what you pay, value is what you get. Here, I get a book value of ₹29.12 per share, so the market price of ₹247.97 is about 8.5 times book. That premium could only be justified by exceptional profitability and growth, but ROCE is only 9.9% and return on equity is not even reported—likely weak or negative. The Piotroski F-score of 3/9 indicates poor financial health. Debt-to-equity of 0.85 is not catastrophic, but with falling revenue, debt service can become burdensome. There is no dividend yield; I earn nothing while waiting. The promoter holding at 73.5% is high, which is sometimes positive, but it does not compensate for deteriorating fundamentals. Is there a moat? In packaged foods, a moat comes from brand loyalty, distribution scale, or cost advantage. I see no evidence of that from these figures—instead, I see a business losing traction. This looks like a value trap rather than an opportunity. A distressed or turnaround situation requires a margin of safety and a clear path back to growth. I find neither here. At this price, the downside seems far larger than the upside. I will wait on the sidelines until the company can demonstrate consistent recovery, stabilize sales, and earn a return on capital that justifies its valuation. For now, this is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer